New tests for Alzheimer’s and cancer get FDA’s ‘breakthrough’ status
New in STAT's Breakthrough Devices Tracker: An AI-powered disease detection chatbot, and new tests for cancer, Alzheimer's.

A disease detection chatbot powered by generative AI and four cancer tests are among the latest medical devices to receive “breakthrough” status from the Food and Drug Administration.
The FDA granted breakthrough designation to devices from at least 15 medical technology companies between December and mid-March, STAT found. You can learn more about these, as well as other devices that have so far received the designation, using STAT’s Breakthrough Device Tracker.